ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 318 filers reported holding ASTRAZENECA PLC in Q2 2013. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $148,182,560 | +0.6% | 1,900,020 | -12.6% | 0.05% | 0.0% |
Q1 2024 | $147,348,323 | +47.8% | 2,174,883 | +46.9% | 0.05% | +36.8% |
Q4 2023 | $99,692,144 | -4.1% | 1,480,210 | -3.6% | 0.04% | -13.6% |
Q3 2023 | $103,994,150 | +623.8% | 1,535,649 | +665.0% | 0.04% | +633.3% |
Q2 2023 | $14,366,819 | +60.1% | 200,738 | +55.2% | 0.01% | +50.0% |
Q1 2023 | $8,976,309 | -30.9% | 129,323 | -32.5% | 0.00% | -33.3% |
Q4 2022 | $12,992,989 | -21.7% | 191,637 | -36.7% | 0.01% | -25.0% |
Q3 2022 | $16,593,000 | -44.0% | 302,562 | -32.5% | 0.01% | -42.9% |
Q2 2022 | $29,628,000 | -75.1% | 448,435 | -75.0% | 0.01% | -69.6% |
Q1 2022 | $118,973,000 | -35.3% | 1,793,381 | -43.2% | 0.05% | -29.2% |
Q4 2021 | $183,899,000 | -0.7% | 3,157,065 | +2.3% | 0.06% | -11.0% |
Q3 2021 | $185,275,000 | -26.0% | 3,084,840 | -26.2% | 0.07% | -27.0% |
Q2 2021 | $250,303,000 | +1667.2% | 4,178,673 | +1366.8% | 0.10% | +1566.7% |
Q1 2021 | $14,164,000 | +1806.3% | 284,874 | +1817.1% | 0.01% | – |
Q4 2020 | $743,000 | -41.2% | 14,860 | -35.6% | 0.00% | -100.0% |
Q3 2020 | $1,264,000 | -77.9% | 23,067 | -78.7% | 0.00% | -66.7% |
Q2 2020 | $5,728,000 | +61.0% | 108,295 | +36.0% | 0.00% | 0.0% |
Q1 2020 | $3,557,000 | +19.2% | 79,643 | +33.0% | 0.00% | +50.0% |
Q4 2019 | $2,985,000 | +34.2% | 59,861 | +20.0% | 0.00% | +100.0% |
Q3 2019 | $2,224,000 | -52.6% | 49,900 | -56.1% | 0.00% | -66.7% |
Q2 2019 | $4,689,000 | +43.5% | 113,598 | +40.5% | 0.00% | +50.0% |
Q1 2019 | $3,268,000 | -1.3% | 80,825 | -7.3% | 0.00% | 0.0% |
Q4 2018 | $3,312,000 | -93.1% | 87,210 | -92.8% | 0.00% | -93.5% |
Q3 2018 | $48,165,000 | -4.2% | 1,217,208 | -15.0% | 0.03% | -11.4% |
Q2 2018 | $50,273,000 | +1815.2% | 1,431,883 | +1807.3% | 0.04% | +1650.0% |
Q1 2018 | $2,625,000 | +1788.5% | 75,072 | +3583.6% | 0.00% | – |
Q1 2015 | $139,000 | -5.4% | 2,038 | -2.4% | 0.00% | – |
Q4 2014 | $147,000 | -5.8% | 2,088 | -4.1% | 0.00% | – |
Q3 2014 | $156,000 | -79.6% | 2,178 | -78.8% | 0.00% | -100.0% |
Q2 2014 | $763,000 | +3.1% | 10,271 | -10.0% | 0.00% | 0.0% |
Q1 2014 | $740,000 | +106.7% | 11,411 | +89.1% | 0.00% | – |
Q4 2013 | $358,000 | -46.9% | 6,033 | -53.5% | 0.00% | -100.0% |
Q3 2013 | $674,000 | -77.3% | 12,988 | -79.3% | 0.00% | -66.7% |
Q2 2013 | $2,973,000 | – | 62,856 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |